137 related articles for article (PubMed ID: 28329483)
1. The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.
Navarrete-Dechent C; Molgó M
Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329483
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effects of Sunscreens Alone vs Sunscreens Plus DNA Repair Enzymes in Patients With Actinic Keratosis: Clinical and Molecular Findings from a 6-Month, Randomized, Clinical Study.
Carducci M; Pavone PS; De Marco G; Lovati S; Altabas V; Altabas K; Emanuele E
J Drugs Dermatol; 2015 Sep; 14(9):986-90. PubMed ID: 26355618
[TBL] [Abstract][Full Text] [Related]
5. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.
Moscarella E; Argenziano G; Longo C; Aladren S
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e401-e403. PubMed ID: 28294419
[No Abstract] [Full Text] [Related]
6. A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.
Eibenschutz L; Silipo V; De Simone P; Buccini PL; Ferrari A; Carbone A; Catricalà C
Br J Dermatol; 2016 Dec; 175(6):1391-1393. PubMed ID: 27167413
[No Abstract] [Full Text] [Related]
7. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
8. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
9. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Gebauer K; Shumack S; Cowen PS
Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
[TBL] [Abstract][Full Text] [Related]
10. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
[TBL] [Abstract][Full Text] [Related]
11. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
12. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study.
Veronese F; Zavattaro E; Orioni G; Landucci G; Tarantino V; Airoldi C; Savoia P
J Dermatolog Treat; 2021 Sep; 32(6):625-630. PubMed ID: 31689138
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
16. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
17. Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.
Piquero-Casals J; Morgado-Carrasco D; Gilaberte Y; Del Rio R; Macaya-Pascual A; Granger C; López-Estebaranz JL
Dermatol Ther (Heidelb); 2020 Oct; 10(5):903-915. PubMed ID: 32681454
[TBL] [Abstract][Full Text] [Related]
18. Field cancerization in clinically solitary actinic keratosis: A pilot study.
Micali G; Verzì AE; Barresi S; Dirschka T; Lacarrubba F
Dermatol Ther; 2021 Jan; 34(1):e14607. PubMed ID: 33249729
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.
Bobyr I; Campanati A; Giacchetti A; Offidani A
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):277-279. PubMed ID: 30690758
[No Abstract] [Full Text] [Related]
20. A Novel Technology: Sunscreen With Actinic Damage Repair.
Kircik Md LH
J Drugs Dermatol; 2017 May; 16(5):s59-s60. PubMed ID: 28628692
[No Abstract] [Full Text] [Related]
[Next] [New Search]